Content authored by practitioners with experience at Amazon India, Intuit QuickBooks, and the Tata Group. Meet the team →
A Tier-1 integrated pharma formulator running a Hyderabad plant with an illustrative August 2026 monthly Chapter 30 outward supply of the order of Rs 42 crore at 5 per cent output must close its books, file GSTR-3B by the twentieth of September, prepare Statement 1A and Statement 3A, compute the Rule 89(5) Maximum Refund Amount, draft the Rule 89(2)(l) declaration and Undertaking, upload the RFD-01 on the common portal, track the Form GST RFD-02 acknowledgement inside the fifteen-day Rule 90 clock, track the Section 54(6) provisional refund of 90 per cent inside the seven-day clock from acknowledgement, respond to any Form GST RFD-03 deficiency memo, and track the final Form GST RFD-06 sanction — all while the two-year filing window under Section 54 continues to run against the plant. The workflow must reconcile the RFD-01 draft against GSTR-3B Table 4 (eligible ITC) and Table 3.1 (outward tax liability), the Statement 1A input register against the plant's own purchase register and the GSTR-2B, the Statement 3A outward register against the filed GSTR-1, and the Section 54(6) provisional refund tracker against the treasury projection.
The workflow runs in fifteen sequential steps per GSTIN per tax period. Close the plant's input register on the last day of the tax period. Reconcile the plant's accounting ITC ledger against the auto-populated GSTR-2B at invoice level. File GSTR-3B by the twentieth of the following month with Table 4 eligible ITC and Table 3.1 outward tax liability populated. Extract the outward supply detail from the filed GSTR-1. Build the Net ITC composition register decomposed by input HSN chapter, holding input-services and capital-goods ITC in separate ledgers that do not feed the Rule 89(5) numerator. Compute the Maximum Refund Amount using the Notification 14/2022 amended formula. Prepare Statement 1A (invoice-level input register) and Statement 3A (outward supply invoice register). Draft the Rule 89(2)(l) declaration and the Undertaking. Upload the RFD-01 with annexures. Track the RFD-02 acknowledgement inside the fifteen-day Rule 90 clock. Respond to any RFD-03 deficiency memo and refile. Track the RFD-04 provisional refund of 90 per cent inside the Section 54(6) seven-day clock from acknowledgement. Respond to any RFD-08 show-cause notice. Track the final RFD-06 sanction and update the treasury projection against the accumulated inverted-duty ITC position.
Plant master with GSTIN, state, tax-period cutover calendar, and the RFD-01 filing-window monitor keyed to the two-year Section 54 clock. Input HSN register keyed to Chapter 29 (2941 antibiotics, other organic chemicals), Chapter 30 (3003 bulk drug mixtures), Chapter 27 (industrial solvents — hexane, isopropyl alcohol, methanol, toluene, methyl ethyl ketone), Chapter 39 (polymer films, HDPE bottles, blister foils), Chapter 48 (cartons, leaflets), and excipient chapters 11, 17, 38, 3505. Net ITC composition register per HSN chapter per tax period with input-services and capital-goods ITC held separate. GSTR-3B Table 4 and Table 3.1 tie-out to the Net ITC and outward tax liability lines. Statement 1A invoice-level input register builder tied to the purchase register and GSTR-2B at supplier GSTIN and invoice number granularity. Statement 3A outward supply invoice register builder tied to the filed GSTR-1. Rule 89(2)(l) declaration and Undertaking template library. Form GST RFD-01 through RFD-08 lifecycle tracker with acknowledgement, provisional-refund, deficiency-memo response, and final-sanction date-stamps. Treasury projection against the Section 54(6) provisional refund of 90 per cent and the final Section 54(5) sanction timing.
A month-end multi-plant Section 54(3) RFD-01 filing pack per GSTIN: filed GSTR-3B with Table 4 and Table 3.1 populated, filed GSTR-1 outward supply detail, Rule 89(5) Maximum Refund Amount computation with amended-formula step, Net ITC composition decomposed by input HSN chapter with the Chapter 27 solvent proportion disclosed as a distinct line, Statement 1A and Statement 3A annexures tied out to the purchase register and outward register at invoice level, Rule 89(2)(l) declaration and Undertaking, RFD-01 draft ready for portal upload, and a rolling lifecycle tracker following RFD-02 acknowledgement, RFD-04 provisional refund, any RFD-03 deficiency memo response, and RFD-06 final sanction. A parallel treasury projection maps each filed RFD-01 to its expected 90 per cent provisional receipt inside the Section 54(6) seven-day window from acknowledgement, and to the final ten per cent balance receipt post Section 54(5) verification, so the finance team can size the working-capital gap between accrued refund and cash receipt at the plant and network level.
A Tier-1 integrated pharma formulator running a Hyderabad plant closes its books for August 2026 — a tax period run entirely under the post-22-September-2025 GST rate regime. Chapter 30 medicaments (heading 3004 finished dosage forms; heading 3003 bulk drug mixtures) sit at a flat 5 per cent GST output rate. The plant’s packaging inputs remain at 18 per cent under HSN Chapters 39 and 48. Solvent inputs used in the wet-granulation and API-purification steps — hexane, isopropyl alcohol, methanol, toluene, methyl ethyl ketone — remain at 18 per cent under HSN Chapter 27. Active pharmaceutical ingredients sit at 5 per cent under HSN Chapter 29 (2941 for antibiotics) or Chapter 30 (3003 for bulk drug mixtures). At an illustrative August 2026 monthly Chapter 30 outward supply of the order of Rs 42 crore, the plant accumulates unutilised inverted-duty ITC in the electronic credit ledger that must be recovered by way of a Section 54(3) refund claim filed monthly on Form GST RFD-01 on the common portal. This is the Section 54(3) CGST RFD-01 pharma inverted duty filing workflow at operating scale, and the discipline that separates a defensible fifteen-step monthly filing cycle from a deficiency-memo loop is a fully mapped workflow that ties out the RFD-01 draft against GSTR-3B Table 4 and Table 3.1, ties Statement 1A against the plant’s purchase register and the GSTR-2B, and tracks the Section 54(6) provisional refund of 90 per cent inside the seven-day clock from acknowledgement.
Quick reference
| Aspect | Detail |
|---|---|
| Refund provision | Section 54(3), CGST Act 2017 (inverted duty structure) |
| Provisional refund | Section 54(6), CGST Act 2017 (90 per cent within seven days of acknowledgement) |
| Refund formula | Rule 89(5), CGST Rules 2017, as amended by Notification 14/2022 |
| Refund application form | Form GST RFD-01 (electronic) |
| Acknowledgement form | Form GST RFD-02 (within fifteen days of complete filing) |
| Deficiency memo form | Form GST RFD-03 |
| Provisional refund order | Form GST RFD-04 (up to 90 per cent within seven days of RFD-02) |
| Payment advice | Form GST RFD-05 |
| Final sanction order | Form GST RFD-06 (after Section 54(5) verification) |
| Withholding/adjustment order | Form GST RFD-07 |
| Show-cause notice | Form GST RFD-08 |
| Invoice-level input annexure | Statement 1A (per Rule 89(2)) |
| Outward supply annexure | Statement 3A |
| Declaration | Rule 89(2)(l) declaration + Undertaking |
| Filing window | Two years from relevant date under Section 54 |
| Council FAQ Q10 pledge | Expedited processing of Chapter 30 Section 54(3) refunds |
The reconciliation in one paragraph
A Chapter 30 pharma formulator files Form GST RFD-01 on the common portal every tax period against the unutilised inverted-duty ITC that accumulates because the 5 per cent output rate sits materially below the input-weighted rate (Chapter 39 and 48 packaging at 18 per cent, Chapter 27 solvents at 18 per cent, excipients at 5 to 12 per cent, Chapter 29 APIs at 5 per cent). The filing is the endpoint of a fifteen-step monthly workflow: close the input register; reconcile the plant’s accounting ITC against GSTR-2B; file GSTR-3B by the twentieth with Table 4 eligible ITC and Table 3.1 outward tax liability; extract outward supply from the filed GSTR-1; build the Net ITC composition register decomposed by input HSN chapter; compute the Rule 89(5) Maximum Refund Amount using the Notification 14/2022 amended formula that excludes input services and capital goods from Net ITC; prepare Statement 1A (invoice-level input register) and Statement 3A (outward supply register); draft the Rule 89(2)(l) declaration and the Undertaking; upload RFD-01 on the portal; track the Form GST RFD-02 acknowledgement (fifteen-day clock under Rule 90); respond to any Form GST RFD-03 deficiency memo; track the Section 54(6) provisional refund of 90 per cent in Form GST RFD-04 (seven-day clock from acknowledgement); respond to any Form GST RFD-08 show-cause notice; and track the final Form GST RFD-06 sanction. The complete Rule 89(5) refund playbook for pharma formulations is the cornerstone reference for the underlying formula mechanic.
What the scenario looks like in India
Indian pharma formulation capacity concentrates around a handful of state clusters. The Telangana belt — Hyderabad, Bachupally, Bollaram, and the Vishakhapatnam anchor across the state border — hosts a dense footprint of Tier-1 integrated formulators and API-plus-formulation majors. Historically the Baddi cluster in Himachal Pradesh and the Sikkim cluster carried the post-2010 formulation capacity built under the area-based excise and Section 80-IE income-tax exemption regimes. The Gujarat corridor — Ahmedabad, Vadodara, Halol, Ankleshwar — anchors integrated Chapter 29 API-to-Chapter 30 formulation flows. Maharashtra’s Kurkumbh and Goa’s Verna round out the geographic spread. Each plant sits under a separate state GSTIN, files its own GSTR-1 and GSTR-3B, and files its own Form GST RFD-01 monthly against the accumulated inverted-duty ITC on its electronic credit ledger.
Illustrative Tier-1 and Tier-2 listed formulators running multi-plant Chapter 30 output networks at the scale relevant to this workflow include Sun Pharma, Dr Reddy’s Laboratories, Cipla, Aurobindo Pharma, Lupin, Zydus Lifesciences, Torrent Pharmaceuticals, Alkem, Glenmark, and Cadila Pharmaceuticals. Tier-2 speciality formulators with multi-plant footprints include Biocon Biologics, Piramal Pharma, Ipca Laboratories, Ajanta Pharma, Natco Pharma, Laurus Labs, Granules India, Strides Pharma Science, and JB Chemicals. Divi’s Laboratories and Neuland Laboratories skew to Chapter 29 API output rather than Chapter 30 formulation but run parallel inversion cycles under the same Rule 89(5) mechanic.
For this workflow walkthrough, the reference persona is a Tier-1 integrated formulator running a Hyderabad plant with an illustrative August 2026 monthly Chapter 30 outward supply of the order of Rs 42 crore against a Net ITC pool of the order of Rs 8.5 crore, filing a single Form GST RFD-01 against the Telangana state GSTIN in September 2026 for the August tax period.
The regulatory overlay — Section 54(3), Section 54(6), Rule 89, Rule 90 and the RFD-form lifecycle
Two Sections and two Rules govern the RFD-01 workflow, and the operational teeth sit in the RFD-01 through RFD-08 form lifecycle.
Section 54(3) of the CGST Act 2017 is the substantive right — a registered person may claim refund of unutilised input tax credit at the end of any tax period where the credit has accumulated on account of the rate of tax on inputs being higher than the rate of tax on output supplies. Section 54(6) is the operational lever — the proper officer may refund on a provisional basis 90 per cent of the total amount claimed within seven days from the date of acknowledgement of the application, with the balance released after Section 54(5) verification. Rule 89(1) prescribes that the refund application is filed electronically in Form GST RFD-01 on the common portal. Rule 89(2) prescribes the documentary annexures — Statement 1A for the inverted-duty invoice-level input register, Statement 3A for the outward supply invoice register, the Rule 89(2)(l) declaration that the incidence of tax has not been passed on, and the Undertaking that the applicant will refund any amount granted in excess. Rule 89(5), as amended by Notification 14/2022-Central Tax dated 5 July 2022, gives the Maximum Refund Amount formula: (Turnover of inverted-rated supply × Net ITC / Adjusted Total Turnover) minus (Tax payable on such inverted-rated supply × Net ITC / ITC availed on inputs and input services), with Net ITC excluding input services and capital goods.
Rule 90 governs the acknowledgement and deficiency memo lifecycle. The proper officer issues Form GST RFD-02 acknowledging the application within fifteen days of filing if the application is complete; the Section 54(6) seven-day clock for the provisional refund runs from the date of the RFD-02 acknowledgement, not the date of RFD-01 filing. If the application is incomplete the officer issues a Form GST RFD-03 deficiency memo, the original RFD-01 is treated as not filed, and the two-year filing window under Section 54 continues to run against the taxpayer. Form GST RFD-04 is the provisional refund order releasing the 90 per cent within the Section 54(6) window; Form GST RFD-05 is the payment advice released to the disbursement bank; Form GST RFD-06 is the final refund sanction after Section 54(5) verification; Form GST RFD-07 is the order for adjustment or withholding; Form GST RFD-08 is the show-cause notice preceding any rejection.
The 56th GST Council meeting held on 3 September 2025, effective 22 September 2025, is the reason the workflow moved from a bimonthly-or-quarterly rhythm to a firmly monthly rhythm — the Council FAQ Q10 pledge of expedited processing for Chapter 30 formulator Section 54(3) refunds materially compressed the acknowledgement-to-sanction window. Departmental practice observed post-reset places complete pharma RFD-01 filings for Chapter 30 formulators in the twenty-day filing-to-RFD-04 window against the pre-reset thirty-to-forty-five-day norm — the FAQ Q10 pledge is operative and the filing discipline should be structured to capitalise on it.
A worked example — August 2026 Hyderabad plant
Illustrative — the figures below represent the operating pattern of a Tier-1 pharma formulator running a Hyderabad plant at Tier-1 listed-formulator scale. Public disclosures do not reveal per-plant per-month RFD-01 refund quantum in the granularity below; cross-verify against your own plant’s GSTR-1, GSTR-2B and GSTR-3B extracts before action.
The plant closes August 2026 with the following position:
| Reconciliation line | Value (Rs crore) | Notes |
|---|---|---|
| Turnover of inverted-rated supply (Chapter 30 output, 5 per cent) | 42.00 | Statement 3A total |
| Adjusted Total Turnover for the tax period | 42.00 | Plant output is entirely Chapter 30 inverted-rated |
| Tax payable on inverted-rated supply (5 per cent of 42.00) | 2.10 | GSTR-3B Table 3.1 outward tax liability |
| Net ITC (eligible-input ITC after excluding input services and capital goods) | 8.50 | Rule 89(5) numerator base; Statement 1A total |
| Aggregate ITC availed on inputs + input services (Rule 89(5) second-limb denominator) | 9.80 | GSTR-3B Table 4 eligible ITC excluding capital goods |
Applying the Notification 14/2022 amended Rule 89(5) formula: first limb = (42.00 × 8.50 / 42.00) = Rs 8.50 crore; second limb = (2.10 × 8.50 / 9.80) = Rs 1.82 crore; Maximum Refund Amount = 8.50 − 1.82 = Rs 6.68 crore. Under a simplified interpretation used in some filings — the second-limb tax-payable subtraction taken as an unratioed amount — the computation reads Max Refund = 8.50 − 2.10 = Rs 6.40 crore. The defensible position under the Notification 14/2022 amended formula is the Rs 6.68 crore figure, but conservative-filing practice at some proper officers is to accept the simplified Rs 6.40 crore. The reconciliation discipline is to hold both computations in the workbook, file at the amended-formula quantum, and be prepared to defend the ratio treatment at scrutiny.
The RFD-01 draft ties out against the filed GSTR-3B Table 4 (eligible ITC of Rs 9.80 crore, with capital-goods ITC held separately) and GSTR-3B Table 3.1 (outward tax liability of Rs 2.10 crore). The Statement 1A total (Rs 8.50 crore) ties out invoice-by-invoice to the plant’s purchase register and to the GSTR-2B goods-input ITC pool. The Statement 3A total (Rs 42.00 crore) ties out invoice-by-invoice to the filed GSTR-1. The Rule 89(2)(l) declaration and the Undertaking are executed. The RFD-01 is uploaded on the common portal on 22 September 2026 (T+22 from the tax-period end). The proper officer issues Form GST RFD-02 acknowledgement on 24 September 2026 (T+24). The Section 54(6) seven-day clock for the provisional refund starts on 24 September; Form GST RFD-04 releases 90 per cent (Rs 6.01 crore against the Rs 6.68 crore claim) by 1 October 2026 (T+31 from the tax-period end). The final Form GST RFD-06 sanction for the balance ten per cent follows post-scrutiny in the T+45 to T+60 window. The Council FAQ Q10 expedited-pledge target of T+20 for the RFD-04 provisional refund is met when the RFD-01 is filed at T+15 with a complete Statement 1A that does not trigger an RFD-03 deficiency memo.
Common reconciliation breakages
Five breakages recur across Indian Chapter 30 pharma formulator RFD-01 filings and each maps to a specific control failure that a Form GST RFD-03 deficiency memo will surface.
-
Statement 1A total not tying to the Net ITC declared in the RFD-01 body. The most frequent deficiency memo trigger. The Net ITC line in the RFD-01 body and the aggregate CGST/SGST/IGST across Statement 1A rows must reconcile to the paise. Rounding differences at the invoice-value level accumulated across several hundred purchase invoices produce a five-to-ten-rupee variance that the portal rejects at upload validation. Reconciliation discipline: the Statement 1A builder rounds at aggregate level, not row level, so the total ties exactly to the Net ITC declared.
-
Input-services or capital-goods ITC included in the Rule 89(5) numerator. The Net ITC in the Rule 89(5) formula excludes input services (freight on inbound raw materials, external analytical laboratory services, engineering consulting, plant maintenance contracts) and capital goods (reactors, granulators, compression machines, blister packaging lines). Formulators that treat the entire GSTR-2B ITC pool as Net ITC produce an overstated refund claim that the proper officer partially rejects with a Form GST RFD-03 deficiency memo. The exclusion was codified by Notification 14/2022-Central Tax and settled by the Supreme Court in Union of India v. VKC Footsteps.
-
Chapter 27 solvent proportion of Net ITC undisclosed. Notification 09/2022-Central Tax (Rate) dated 13 July 2022 bars Section 54(3) refund on output supplies falling under HSN Chapter 15 or Chapter 27. The direct legal footprint sits on the output side (a Chapter 27 solvent seller cannot claim inverted-duty refund on its own inversion) — the edible oil Chapter 15 refund-blocked walkthrough documents the mirror mechanic for the Chapter 15 leg of the same notification. For a Chapter 30 formulator whose Net ITC includes a Chapter 27 solvent input proportion, the RFD-01 discipline is to disclose the solvent leg as a distinct line in Statement 1A so any officer challenge under an interpretive carve-out reading is answered with the invoice-level solvent register rather than an aggregate ITC pool.
-
Statement 3A outward register not tying to the filed GSTR-1. Statement 3A carries the invoice-level outward supply detail supporting the Turnover of inverted-rated supply in the Rule 89(5) numerator. Every invoice in Statement 3A must exist in the filed GSTR-1 for the tax period, with the taxable value and tax amount matching to the paise. Amendment invoices, credit notes, and any B2B outward supply not carried forward to GSTR-1 produce a Statement 3A vs GSTR-1 reconciliation exception and an RFD-03 deficiency memo. The GSTR-2B ITC reconciliation failure-mode reference covers the mirror mechanic for the Statement 1A vs GSTR-2B input-side tie-out.
-
Rule 89(2)(l) declaration and Undertaking missing or improperly executed. Rule 89(2)(l) requires a declaration by the applicant certifying that the incidence of the tax and interest claimed as refund has not been passed on to any other person. A separate Undertaking commits the applicant to refund any amount granted in excess. Both documents must be executed on the applicant’s letterhead and uploaded alongside the RFD-01. Formulators that omit either or execute them incorrectly produce an RFD-03 deficiency memo at the acknowledgement stage. The declaration is a standard-form document but the pass-through-of-tax certification requires internal sign-off from the CFO or authorised signatory each month.
How a reconciliation platform handles this
A purpose-built pharma reconciliation platform ingests the plant’s GSTR-1 outward supply register, GSTR-2B auto-populated ITC statement, GSTR-3B filed return, and internal purchase register — and produces the fifteen-step RFD-01 filing pack per plant per tax period: the Net ITC composition register decomposed by input HSN chapter with the Chapter 27 solvent proportion disclosed as a distinct line, the Rule 89(5) amended-formula Maximum Refund Amount computation with both the ratio-treatment and simplified-treatment values held for scrutiny defence, the Statement 1A input register tied out invoice-by-invoice to the purchase register and GSTR-2B, the Statement 3A outward register tied out invoice-by-invoice to the filed GSTR-1, the Rule 89(2)(l) declaration and Undertaking auto-populated from the plant master, the RFD-01 draft ready for portal upload, and a rolling lifecycle tracker following the RFD-02 acknowledgement, RFD-04 provisional refund, any RFD-03 deficiency memo response, and RFD-06 final sanction against a treasury projection. Match rate improvement of 51 to 88 per cent on the plant-level Statement 1A vs GSTR-2B and Statement 3A vs GSTR-1 tie-outs, combined with an ISO 27001:2022 posture and DPDP Act 2023 aligned data handling, is what turns the platform into an infrastructure investment for a Tier-1 pharma formulator running a multi-plant Chapter 30 network — cycles the filing-to-provisional-refund window into the Council FAQ Q10 expedited T+20 target rather than the pre-reset T+30 to T+45 default.
Cross-cluster bridges and where to read next
The Section 54(3) RFD-01 workflow documented here rests on the underlying Rule 89(5) formula mechanic — read the Rule 89(5) inverted duty refund pharma formulations complete guide as the Wave A cornerstone. The Rule 89(5) mechanic is common across inverted-duty industries; for the dairy sector, where 5 per cent packaged milk output against 18 per cent packaging input creates a structurally similar inversion cycle, the dairy inverted-duty refund under Rule 89(5) post GST 2.0 walkthrough is the cross-cluster anchor.
The methodology framework for the standing RFD-01 close discipline — mapping every filing step to a reconciliation control, holding both base-case and defence-case computations, and building the deficiency-memo response cycle into the monthly close — sits in Terra Insight’s reconciliation failure mode analysis design-layer pillar and the reconciliation playbook for monthly close operations-layer pillar. The commercial pillar for the pharma sub-cluster is Pharma reconciliation software India; the broader authority for the platform is reconciliation software India with the specialised GST reconciliation software surface for the Section 54(3) refund workflow.
The five FAQs below address the operational questions Indian pharma indirect-tax leads and Chapter 30 plant controllers ask most often when building a standing monthly Form GST RFD-01 filing cycle post the 22 September 2025 GST rate reset.
Content authored by practitioners with experience at Amazon India, Intuit QuickBooks, and the Tata Group. Meet the team →
- ▸ Section 54(3) and Section 54(6), Central Goods and Services Tax Act 2017 — Section 54(3) permits a registered person to claim refund of unutilised input tax credit at the end of any tax period where the credit has accumulated on account of the rate of tax on inputs being higher than the rate of tax on output supplies (the inverted duty structure), subject to the first proviso empowering the government to notify supplies against which such refund shall not be allowed. Section 54(6) provides that the proper officer may, in the case of a claim of refund on account of zero-rated supply and, by the operative reading in departmental practice for inverted-duty refunds, on account of inverted duty structure, refund on a provisional basis ninety per cent of the total amount so claimed within seven days from the date of acknowledgement of the refund application, with the balance released after due verification under Section 54(5).
- ▸ Rule 89 and Rule 90, Central Goods and Services Tax Rules 2017 (procedural framework) — Rule 89(1) requires the refund application to be filed electronically in Form GST RFD-01 on the common portal. Rule 89(2) prescribes the documentary evidence and declarations; Statement 1A supports the inverted-duty refund claim with the invoice-level input register; Statement 3A supports the outward supply invoice register; the Rule 89(2)(l) declaration certifies that the incidence of tax has not been passed on. Rule 90 provides for the acknowledgement of the application in Form GST RFD-02, the communication of deficiencies in Form GST RFD-03, and the timeline that the fifteen-day clock for the acknowledgement runs from the date of filing of a complete application.
- ▸ Rule 89(5), Central Goods and Services Tax Rules 2017, as amended by Notification 14/2022-Central Tax dated 5 July 2022 — Maximum Refund Amount = (Turnover of inverted-rated supply of goods and services × Net ITC / Adjusted Total Turnover) minus (Tax payable on such inverted-rated supply × Net ITC / ITC availed on inputs and input services). The 5 July 2022 amendment applies prospectively — applications filed on or after 5 July 2022 use the amended formula. Net ITC expressly excludes input services and capital goods, codifying the Supreme Court position in Union of India v. VKC Footsteps India Pvt Ltd (2021) 10 SCC 674.
- ▸ 56th GST Council Meeting recommendations, 3 September 2025 (effective 22 September 2025) — The Council moved all drugs under HSN Chapter 30 (heading 3003 non-formulation mixtures and heading 3004 formulation preparations) to a flat 5 per cent rate; moved medical devices under HSN 9018 to 9022 from 18 per cent to 5 per cent; and moved a specified schedule of life-saving drugs to nil rate. The accompanying FAQ set — including Q10, Q25 and Q51 — acknowledged that the reset deepens inversion for Chapter 30 formulators and pledged expedited processing of Section 54(3) refunds under the Rule 89(5) framework, materially compressing the acknowledgement-to-sanction window against pre-reset norms.
- ▸ Form GST RFD-01 through Form GST RFD-08 lifecycle, CGST Rules 2017 — Form GST RFD-01 is the electronic refund application. Form GST RFD-02 is the acknowledgement issued when the application is complete. Form GST RFD-03 is the deficiency memo requiring the applicant to file a fresh application. Form GST RFD-04 is the provisional refund order granting up to 90 per cent within seven days of acknowledgement. Form GST RFD-05 is the payment advice released to the disbursement bank. Form GST RFD-06 is the final refund sanction order after Section 54(5) verification. Form GST RFD-07 is the order for complete adjustment or withholding of refund. Form GST RFD-08 is the show-cause notice for rejection.